cost of glp-1 drugs without insurance Drug Savings: A Complete Guide for How to Save on Ozempic, Wegovy, and More Poll: 1 in 8 Adults

GLP-1s are becoming a mainstay for weight loss and diabetes treatment, and the demand for this type of drug is high

Amy Schroeder Principal Research Scientist | July 9, 2025 Current Landscape Overview Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) are an emerging drug class that are mostly indicated to improve glycemic control in patients with type 2 diabetes mellitus (T2D) and reduce body weight

Some evidence points to a threshold of around 1.6 g/kg/day, beyond which additional protein does not promote further muscle gain in most people

Interleukin-10-independent anti-inflammatory actions of glucagon-like peptide 2

The medication has been studied most prominently for managing blood sugar in patients with Type 2 diabetes, meaning some providers may only prescribe it for people with diabetes